Cite
Optimal Dose of Cisplatin (CDDP) Given Concurrently with Radiotherapy (RT) in Locally Advanced Squamous Cell Head and Neck Cancer (SQC HNC).
MLA
Jeremic, Branislav, et al. “Optimal Dose of Cisplatin (CDDP) Given Concurrently with Radiotherapy (RT) in Locally Advanced Squamous Cell Head and Neck Cancer (SQC HNC).” Turkish Journal of Oncology / Türk Onkoloji Dergisi, vol. 35, no. 2, Apr. 2020, pp. 237–41. EBSCOhost, https://doi.org/10.5505/tjo.2020.2247.
APA
Jeremic, B., Dubinsky, P., Jeremic, M., Kiladze, I., & Özyi̇ği̇t, G. (2020). Optimal Dose of Cisplatin (CDDP) Given Concurrently with Radiotherapy (RT) in Locally Advanced Squamous Cell Head and Neck Cancer (SQC HNC). Turkish Journal of Oncology / Türk Onkoloji Dergisi, 35(2), 237–241. https://doi.org/10.5505/tjo.2020.2247
Chicago
Jeremic, Branislav, Pavol Dubinsky, Marta Jeremic, Ivano Kiladze, and Gökhan Özyi̇ği̇t. 2020. “Optimal Dose of Cisplatin (CDDP) Given Concurrently with Radiotherapy (RT) in Locally Advanced Squamous Cell Head and Neck Cancer (SQC HNC).” Turkish Journal of Oncology / Türk Onkoloji Dergisi 35 (2): 237–41. doi:10.5505/tjo.2020.2247.